机译:LSP1、2q35和8q24中的常见变异以及BRCA1和BRCA2突变携带者的乳腺癌风险
1Department of Public Health and Primary Care, Cancer Research UK Genetic Epidemiology Unit, University of Cambridge, Cambridge, UK, 2Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon/Centre Léon Bérard, UMR5201 CNRS, Université de Lyon, Lyon, France, 3Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia, 4Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland, 5Canada Research Chair in Oncogenetics, Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec, Canada, 6Peter MacCallum Cancer Institute, Melbourne VIC 3002, Australia, 7Department of Epidemiology, University of California Irvine, Irvine, CA, USA, 8Mayo Clinic, Rochester, MN, USA, 9Fon;
机译:LSP1、2q35和8q24中的常见变异以及BRCA1和BRCA2突变携带者的乳腺癌风险。
机译:与BRCA1和BRCA2的常见变异相关的对侧乳腺癌的风险:BRCA1 / BRCA2突变携带者状态的潜在修饰作用。
机译:与BRCA1和BRCA2常见变异相关的对侧乳腺癌的风险:BRCA1 / BRCA2突变携带者状态的潜在修饰作用
机译:BRCA1和BRCA2基因在Kabardino-Balkaria的乳腺癌中BRCA2基因的突变频率
机译:BRCA1和BRCA2突变携带者进行化学预防后的乳腺癌风险。
机译:LSP1、2q35和8q24中的常见变异以及BRCA1和BRCA2突变携带者的乳腺癌风险
机译:LSP1、2q35和8q24中的常见变异以及BRCA1和BRCA2突变携带者的乳腺癌风险